New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
07:49 EDTBAXSBaxano Surgical announces $10M private placement of convertible debentures
The debentures will be convertible into common stock at an initial conversion price of $1.06 per share and will bear interest at 6% per year, maturing on March 11, 2017. The warrants will have an initial exercise price of $1.19 per share. Piper Jaffray & Co. served as the lead placement agent and Stifel, Nicolaus and Company served as co-placement agent for the transaction.
News For BAXS From The Last 14 Days
Check below for free stories on BAXS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 18, 2014
07:34 EDTBAXSBaxano Surgical says economic analysis of the AxiaLIF accepted for publication
Baxano Surgical announced that the Journal of Managed Care Medicine, a peer-reviewed national publication, has accepted an economic analysis of the AxiaLIF pre-sacral interbody fusion procedure in comparison to transforaminal lumbar interbody fusion, or TLIF. The analysis, conducted by Scott Parker, MD, Director of the Spinal Column Surgical Quality and Outcomes Research Laboratory at Vanderbilt University, and Dr. Matt McGirt, Carolina Neurosurgery and Spine Associates, Adjunct Associate Professor, University of North Carolina, analyzed the bibliography for AxiaLIF and TLIF procedures and assessed relative costs by looking at reoperation rates, complication rates, blood loss and OR time. The study found that AxiaLIF resulted in an approximately $4,500 lower cost per procedure when looking at these procedural parameters.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use